ProPhase Labs, Inc.
PRPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000868278
No open-market purchases or sales by ProPhase Labs, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $2 in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding ProPhase Labs, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 39 | −11 |
| Shares | 2.78M | 100 | 2.44M | −332.9K (−12.0%) |
| Value | $26.7M | $963 | $18.6M | −$8.14M (−30.4%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held ProPhase Labs, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Chapin Davis, Inc. | 30,000 | $228.6K | 0.12% |
| Victory Capital Management Inc | 14,214 | $108.3K | 0.00% |
Sold out (13)
Institutions that held ProPhase Labs, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Bank of Montreal | 67,900 | $670.9K |
| Cambridge Investment Research Advisors, Inc. | 30,744 | $296.0K |
| Millennium Management LLC | 26,893 | $259.0K |
| ProVise Management Group, LLC | 22,077 | $212.6K |
| HRT Financial LP | 21,238 | $204.0K |
| Trexquant Investment LP | 20,265 | $195.2K |
| Keebeck Wealth Management, LLC | 20,000 | $192.6K |
| Stratos Wealth Partners, LTD. | 18,155 | $174.8K |
| Citigroup Inc | 15,354 | $147.9K |
| Goldman Sachs Group Inc | 13,430 | $129.3K |
| Tower Research Capital LLC (TRC) | 5,925 | $57.0K |
| Dorsey Wright & Associates | 2,074 | $20.0K |
| Simplex Trading, LLC | 848 | $8.00K |
Not filed for Q1 2023 yet (1)
Institutions that held ProPhase Labs, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| CoreCap Advisors, LLC | 100 | $963 |